129 related articles for article (PubMed ID: 36705384)
1. Hepatic failure in a patient with rheumatoid arthritis treated with methotrexate: A case report.
Miyata M; Ishiwata S; Kuroda M; Tasaki K; Migita K; Ohira H
Medicine (Baltimore); 2023 Jan; 102(4):e32711. PubMed ID: 36705384
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-associated primary hepatic lymphoma and cranial neuropathy in a patient with rheumatoid arthritis: A case report with clinical follow-up over a 7-year period.
Park JE; Lee KM; Choi HY; Ahn SE; You MW
Medicine (Baltimore); 2019 Apr; 98(17):e14997. PubMed ID: 31027052
[TBL] [Abstract][Full Text] [Related]
4. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
Matsumoto R; Numata K; Doba N; Hara K; Chuma M; Fukuda H; Nozaki A; Tanaka K; Ishii Y; Maeda S
J Med Ultrason (2001); 2016 Oct; 43(4):545-51. PubMed ID: 27577564
[TBL] [Abstract][Full Text] [Related]
5. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
Osuga T; Ikura Y; Kadota C; Hirano S; Iwai Y; Hayakumo T
Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms.
Ezhilarasan D
Toxicology; 2021 Jun; 458():152840. PubMed ID: 34175381
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
Hirata C; Kenzaka T; Akita H
J Clin Pharm Ther; 2021 Aug; 46(4):1178-1181. PubMed ID: 33768586
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.
Shetty A; Cho W; Alazawi W; Syn WK
Am J Med Sci; 2017 Aug; 354(2):172-181. PubMed ID: 28864376
[TBL] [Abstract][Full Text] [Related]
10. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
11. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis.
Miyagawa K; Shibata M; Noguchi H; Hayashi T; Oe S; Hiura M; Abe S; Harada M
Intern Med; 2015; 54(4):401-5. PubMed ID: 25748956
[TBL] [Abstract][Full Text] [Related]
14. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.
Sakaguchi R; Fujikawa K; Okamoto M; Matsuo E; Matsumoto K; Uchida T; Shin-Ya K; Nakashima M; Mizokami A; Kawakami A
Intern Med; 2019 Nov; 58(21):3167-3171. PubMed ID: 31292392
[TBL] [Abstract][Full Text] [Related]
16. A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
Abe A; Wakaki K; Ishikawa H; Ito S; Murasawa A
Mod Rheumatol; 2018 May; 28(3):550-554. PubMed ID: 26558294
[TBL] [Abstract][Full Text] [Related]
17. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.
Langman G; Hall PM; Todd G
J Gastroenterol Hepatol; 2001 Dec; 16(12):1395-401. PubMed ID: 11851839
[TBL] [Abstract][Full Text] [Related]
18. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
[TBL] [Abstract][Full Text] [Related]
19. Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis.
Walker AM; Funch D; Dreyer NA; Tolman KG; Kremer JM; Alarcón GS; Lee RG; Weinblatt ME
Arthritis Rheum; 1993 Mar; 36(3):329-35. PubMed ID: 8452577
[TBL] [Abstract][Full Text] [Related]
20. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
